David R. Strayer

Upregulation of the 2-5A Synthetase/RNase L Antiviral Pathway Associated with Chronic Fatigue Syndrome

Robert J. Suhadolnik, Nancy L. Reichenbach, Patricia Hitzges et al. · Clinical Infectious Diseases · 1994 · 131 citations

Life Sciences, Biochemistry, Molecular Biology +5

A Controlled Clinical Trial with a Specifically Configured RNA Drug, Poly(I). POly(C12U), in Chronic Fatigue Syndrome

David R. Strayer, William A. Carter, Isadore Brodsky et al. · Clinical Infectious Diseases · 1994 · 129 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine

Takeshi Ichinohe, Shinichi Tamura, Akira Kawaguchi et al. · The Journal of Infectious Diseases · 2007 · 118 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer.

David R. Strayer, William A. Carter, Sheila D. Mayberry et al. · PubMed · 1984 · 103 citations

Medicine, Oncology, Cancer Prevention +8

Results of a double-blind placebo-controlled study of the double-stranded RNA drug polyI:PolyC12U in the treatment of HIV infection

Kenneth Thompson, David R. Strayer, P Salvato et al. · European Journal of Clinical Microbiology & Infectious Diseases · 1996 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +10